AllianceBernstein’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-131,235
Closed -$13.4M 3200
2023
Q2
$13.4M Buy
131,235
+62,262
+90% +$6.35M 0.01% 996
2023
Q1
$6.27M Sell
68,973
-44,366
-39% -$4.03M ﹤0.01% 1309
2022
Q4
$4.31M Buy
113,339
+78,439
+225% +$2.98M ﹤0.01% 1499
2022
Q3
$877K Hold
34,900
﹤0.01% 2359
2022
Q2
$1.06M Buy
34,900
+800
+2% +$24.3K ﹤0.01% 2308
2022
Q1
$1.12M Buy
34,100
+100
+0.3% +$3.28K ﹤0.01% 2374
2021
Q4
$897K Sell
34,000
-200
-0.6% -$5.28K ﹤0.01% 2502
2021
Q3
$3.44M Hold
34,200
﹤0.01% 1806
2021
Q2
$4.84M Buy
34,200
+24,931
+269% +$3.53M ﹤0.01% 1628
2021
Q1
$924K Sell
9,269
-2,681
-22% -$267K ﹤0.01% 2432
2020
Q4
$1.48M Sell
11,950
-100
-0.8% -$12.4K ﹤0.01% 2130
2020
Q3
$1.17M Buy
12,050
+650
+6% +$63.3K ﹤0.01% 2105
2020
Q2
$1.78M Sell
11,400
-34,830
-75% -$5.44M ﹤0.01% 1896
2020
Q1
$6.67M Buy
46,230
+400
+0.9% +$57.7K ﹤0.01% 1054
2019
Q4
$9.37M Buy
45,830
+20,030
+78% +$4.09M 0.01% 1110
2019
Q3
$2.07M Hold
25,800
﹤0.01% 1886
2019
Q2
$2.43M Sell
25,800
-500
-2% -$47.2K ﹤0.01% 1847
2019
Q1
$2.25M Buy
26,300
+2,800
+12% +$239K ﹤0.01% 1823
2018
Q4
$1.32M Sell
23,500
-100
-0.4% -$5.61K ﹤0.01% 2060
2018
Q3
$1.93M Buy
23,600
+5,700
+32% +$466K ﹤0.01% 1957
2018
Q2
$626K Buy
17,900
+1,800
+11% +$63K ﹤0.01% 2521
2018
Q1
$330K Buy
16,100
+1,900
+13% +$38.9K ﹤0.01% 2655
2017
Q4
$402K Hold
14,200
﹤0.01% 2595
2017
Q3
$442K Hold
14,200
﹤0.01% 2603
2017
Q2
$449K Buy
14,200
+3,200
+29% +$101K ﹤0.01% 2632
2017
Q1
$249K Hold
11,000
﹤0.01% 2763
2016
Q4
$240K Hold
11,000
﹤0.01% 2800
2016
Q3
$290K Buy
+11,000
New +$290K ﹤0.01% 2696